ArticleScientific reports2016

miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer.

Merve Mutlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.